Tag: Evolut Pro

Evolut gets CE mark in low-risk patients and new labelling for bicuspid use

Medtronic has been awarded CE mark for the use of the Evolut transcatheter aortic valve implanta...

Bicuspid TAVI outcomes as good as those for tricuspid

Clinical and echocardiographic outcomes at 30 days and one year were similar between patients wi...

FDA approves Evolut PRO+

The US Food and Drug Administration (FDA) has approved the Evolut PRO+ transcatheter aortic valv...

TAVI pacemaker issue is “an engineering problem that will be solved”

The SURTAVI trial indicates that transcatheter aortic valve implantation (TAVI)  with CoreValve/...

ACC 2017: FDA approves launch of CoreValve Evolut Pro

The FDA has approved Medtronic’s CoreValve Evolut Pro transcatheter aortic valve implantation (T...